In Vivo T Cell Depletion Using Rabbit Derived ATG Leads to An Increased EBV-PTLD Risk Due to An Induced Imbalance Between B and T Cell Recovery Which Is Not Seen After Horse Derived ATG or Alemtuzumab
Author(s):
Halkes, C.J.M.; Falkenburg, J.H.F.; Egmond, H.M. van; Wolbers, J.O.; Starrenburg, C.W.J.; Balen, P. van; Meent, M. van de; Borne, P.A. von dem; Marijt, W.A.F.; Veelken, J.H.; Jedema, I.
